心力衰竭患者的心肌去甲肾上腺素摄取显像（mIBG）。
Cardiac sympathetic imaging with mIBG in heart failure.
机构信息
Hospital Sant Pau, Barcelona, Spain.
出版信息
JACC Cardiovasc Imaging. 2010 Jan;3(1):92-100. doi: 10.1016/j.jcmg.2009.07.014.
PMID:20129538
Abstract
Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF.
摘要
使用间碘苄胍（mIBG）进行心脏交感神经显像，是一种用于心力衰竭（HF）患者进行风险分层的非侵入性工具。在缺血性和非缺血性心肌病患者中，心脏 mIBG 活性是生存的一个非常有力的预测指标。心脏交感神经显像有助于了解交感神经过度活跃如何产生有害作用，这可能会为 HF 患者带来更好的治疗和预后。
Zotero 插件